Canada now has enough COVID-19 vaccine doses to fully vaccinate all eligible citizens: PM - CTV News | Canada News Media
Connect with us

News

Canada now has enough COVID-19 vaccine doses to fully vaccinate all eligible citizens: PM – CTV News

Published

 on


OTTAWA —
Canada currently has enough doses of COVID-19 vaccines in the country to fully vaccinate every eligible person over the age of 12, with more than 66 million doses received as of Tuesday.

Prime Minister Justin Trudeau marked the vaccine milestone at a Moncton, N.B. vaccination clinic.

“Back in the winter I made a promise that we would have enough vaccines for all eligible Canadians by the end of September. Not only have we kept that promise, we’ve done it two months ahead of schedule,” Trudeau said.

In June, Trudeau promised that by the end of this month, Canada would have received “over 68 million” doses of COVID-19 vaccines, prompting an acceleration to his initial plans for a “one-dose summer” and “two-dose fall.”

Procurement Minister Anita Anand echoed the announcement later on Tuesday, confirming that by the end of the week, Canada will have received 68 million shots, with millions more coming in the next two months.

“We have procured in total 51 million doses of Pfizer, 44 million doses of Moderna, and we will receive 95 million doses of both of those vaccine manufacturers prior to the end of September,” said Anand.

Reflecting on the rollout, Anand—who led the government’s deal-making with companies to secure doses— said the federal strategy was “one of negotiation, and negotiation, and negotiation.”

As of Tuesday morning, according to CTV News’ vaccine tracker, 80 per cent of the eligible population has received a first dose, while just over 63 per cent of those eligible are fully vaccinated. After trailing behind for months, Canada now has a larger percentage of its population fully vaccinated than any other G7 country. 

‘NO MORE EXCUSES’

While more than 26 million of the eligible 33 million Canadians have rolled up their sleeves, the push is now on to try to reach the outstanding people who are vaccine hesitant or have not yet received a COVID-19 vaccine for other reasons.

Trudeau sought to encourage those still on the fence, reminding people that the vaccines have been authorized as safe and effective by Health Canada, that what the country is seeing is that “overwhelming majority” of new cases are in people who are either unvaccinated or partially vaccinated, and the consequences of getting COVID-19 can be serious.

“With enough doses for everyone, there’s no more excuses to not get your shot,” Trudeau said, encouraging those who have held off to think about their loved ones, the children in their lives, and the health care workers who have been on the front lines for a year and half.

“It’s about stepping up to do the right thing, as Canadians have been doing all throughout this pandemic,” he said, noting that the unvaccinated will be “missing out” on taking part in going forward, citing international travel as an example.

Health Minister Patty Hajdu also spoke about the challenge those who are unwilling to get vaccinated are posing to the country’s overall ability to get through and out of the COVID-19 pandemic.

“My worry as a Canadian health minister is that if we head into the fall and we have too many people that are unvaccinated, it gives the virus an opportunity to attack the people we love… It puts the risk of our recovery—it makes the risk so much more elevated,” she said.

ROLLOUT NOT WITHOUT ISSUES

While Canada’s vaccine rollout has been boosted by large deliveries of doses in recent months — making it possible to rapidly administer second doses — the national mass immunization campaign has not been without its issues.

Since the first COVID-19 vaccines were administered in Canada on December 14, 2020, the rollout has been marked by wildly different challenges including a shortage of doses in some places and seemingly a surplus in others; some Canadians received their two shots just four weeks apart, while others waited four months.

The evolving immunization strategy prompted by supply issues and adverse reaction concerns has resulted in some folks receiving mixed-dose regimes. And, anyone hoping for a single-shot vaccine had their hopes dashed when the only delivery of Johnson & Johnson doses was rejected due to quality control issues. There was also the logistical challenges—from procuring enough needles and cold-storage freezers to setting up administration sites in sometimes unorthodox locations—taken on by each province and territory with help from a military-led federal operations centre within the Public Health Agency of Canada.

On Tuesday, Anand and Hajdu joined representatives from the vaccine companies as well as FedEx Canada and Innomar Strategies, who were contracted by the federal government to help with the delivery and distribution of vaccines at an event marking the vaccine milestone.

“Throughout this pandemic we have rightly thanked our frontline health care workers… Today I would like to thank with immense gratitude, another set of Canadians who have stepped up, and that’s all of you here today… Canadians in the back rooms, who are making sure that we are able to get vaccines into this country,” Anand said, recalling the countless calls, emails, and texts they exchanged over the course of the procurement effort.

WHAT’S NEXT?

Now, the conversation is turning to how long the vaccines will provide protection, and whether evolving variants may prompt booster doses, meaning that while the initial vaccine rollout may be tapering off, COVID-19 and ways to keep future waves at bay will be an ongoing focus for governments and public health officials.

As well, studies are ongoing into the possibility of expanding COVID-19 vaccine access to children under the age of 12, specifically in the ages five to 11 demographic. Pfizer is expecting some early results by the fall, but won’t likely have its work completed to submit to Health Canada for authorization until later in the year.

Anand said that regardless of whether additional doses would be needed or when younger children may be cleared to be immunized against the novel coronavirus, Canada will have the supply.

“We have enough supply for all eligible Canadians and the remainder for additional needs that our country has including additional age groups, or boosters, if the science deems that that is appropriate,” she said.

Adblock test (Why?)



Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version